Regenxbio
RGNX
183 hedge funds and large institutions have $1.26B invested in Regenxbio in 2018 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 86 increasing their positions, 49 reducing their positions, and 43 closing their positions.
76% more repeat investments, than reductions
Existing positions increased: 86 | Existing positions reduced: 49
1.86% more ownership
Funds ownership: 81.68% → 83.54% (+1.9%)
10% less call options, than puts
Call options by funds: $10.6M | Put options by funds: $11.7M
10% less funds holding
Funds holding: 203 → 183 (-20)
42% less capital invested
Capital invested by funds: $2.16B → $1.26B (-$901M)
42% less first-time investments, than exits
New positions opened: 25 | Existing positions closed: 43
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$35.1M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$34.2M |
| 3 |
State Street
Boston,
Massachusetts
|
+$16.4M |
| 4 |
HCM
Highline Capital Management
New York
|
+$12.7M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$11.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RI
RTW Investments
New York
|
-$24M |
| 2 |
DM
Deerfield Management
New York
|
-$20.8M |
| 3 |
Marshall Wace
London,
United Kingdom
|
-$18.7M |
| 4 |
RG
Redmile Group
San Francisco,
California
|
-$17.7M |
| 5 |
Millennium Management
New York
|
-$9.83M |
RGNX Hedge Fund Activity: Q4 2018 in Review
183 of the 4,505 institutional investors tracked by Wall St. Rank reported a position in Regenxbio (RGNX) for Q4 2018, worth a combined $1.26B — down 42% from $2.16B a quarter earlier.
Sellers outnumbered buyers: 43 funds closed out of RGNX and 25 opened new positions — a net loss of 18 holders — while 49 trimmed existing stakes and 86 added.
The largest buyer was Renaissance Technologies, adding an estimated $35.1M. The largest seller was RTW Investments, cutting an estimated $24M.
- 183 institutional investors held Regenxbio (RGNX) as of Q4 2018, down from 203 in Q3 2018.
- Funds reported $1.26B of Regenxbio stock for Q4 2018, down 42% quarter-over-quarter.
- 25 funds opened new Regenxbio positions in Q4 2018 and 43 closed out, a net change of -18 holders.
- The largest Regenxbio buyer in Q4 2018 was Renaissance Technologies, an estimated $35.1M added.
- The largest Regenxbio seller in Q4 2018 was RTW Investments, an estimated $24M sold.
Based on aggregated 13F filings for Q4 2018.